Skip to main content

Into and after the viral storm

The path forward now seems pretty clear. First we get through the grim month-and-more ahead, supporting health care workers in any way we can. (Tip: findthemasks.com lists where to donate PPE, personal protective equipment, in the US. If you have any, do so. We are very literally all in this together, and they need it a lot more than you do.) Then we ramp up massive, pervasive, frequent Covid-19 testing infrastructure everywhere. Then we take stock.

Things will get worse before they get better. Hospitals in some places are already creaking at the seams. The patients entering the ICUs today were infected 3-4 weeks ago. Those infected the day of your local lockdown will reach ICUs 3-4 weeks from that day … and their number doubled every several days between the former batch of infections and the latter. The math is bleak. Many places haven’t locked down yet. They will, hopefully sooner rather than later.

What can we do in tech? Well, here’s an NYC doctor saying “We need our technology friends to be making and testing prototypes to rig the ventilators that we do have to support more than one patient at a time.” Here are the UK government’s specifications for Rapidly Manufactured Ventilator Systems. And here’s a suggestion that people ramp down their Dunning-Kruger armchair epidemiology a little–or a lot. Also:

It’s beyond appalling that the US government is only now realizing that they would more need personal protective equipment, but here we are, beyond appalled. Anything we can do to provide more PPE will be hugely beneficial as well.

Then we need to test, test, test. It is also beyond appalling that America has only recently started testing at scale, and that testing is still hugely restricted, but again, here we are, beyond appalled. We need nationwide, or better yet planetwide, ubiquitous testing.

Ideally we’d want everyone to get tested regularly, maybe weekly, symptomatic or not. Realistically, right now we need to massively expand and expand and expand our testing, and trace the contacts of those who test positive, so we know where the virus is and how many people have it. At the moment we’re all but blind.

Once we know, on a quasi-real-time basis, the numbers of the infected in a given area, we’ll be able to talk about lifting the lockdown. Maybe only for temporary periods, in certain areas, for people who don’t have a fever, lest the virus come roaring back. But the point of pervasive testing-and-tracing is that we’ll know whether that risk exists, and be able to respond appropriately.

Currently we’re making overall progress with testing, but at the same time, in places we’re dialling it back, and we’re limited by test kits, by swabs, by testers, and more. We need much, much more testing capacity to come online in the following months. Once we get there, once the blinding lights of pervasive testing have lit up the virus for us and we can watch it in near real time, then life can slowly begin returning back to normal. Ish.

Maybe then we can start thinking about how, in many places, and in many ways, the pandemic has forced us to start doing the right thing as a temporary emergency measure – everything from housing the homeless, to realizing that it’s grocery workers / janitors / drivers / nurses who are actually essential to our civilization and should be celebrated and rewarded accordingly, to admitting that the liquids limit on airplanes is meaningless, and almost everyone can do their office jobs from home.

Let’s bear that in the back of our minds: but right now, we have a very hard month–and likely months–ahead. I am sorry to be the bearer of bad news, but it is already later and worse than you think. Whatever we all can do to help, we should.



from TechCrunch https://ift.tt/33Eb0tx

Comments

Popular posts from this blog

The hidden cost of food delivery

Noah Lichtenstein Contributor Share on Twitter Noah Lichtenstein is the founder and managing partner of Crossover , a diversified private technology fund backed by institutional investors, technology execs and professional athletes and entertainers. More posts by this contributor What Studying Students Teaches Us About Great Apps I’ll admit it: When it comes to food, I’m lazy. There are dozens of great dining options within a few blocks of my home, yet I still end up ordering food through delivery apps four or five times per week. With the growing coronavirus pandemic closing restaurants and consumers self-isolating, it is likely we will see a spike in food delivery much like the 20% jump China reported during the peak of its crisis. With the food delivery sector rocketing toward a projected $365 billion by the end of the decade, I’m clearly not the only one turning to delivery apps even before the pandemic hit. Thanks to technology (and VC funding) we can get a ri

Political ‘fixer’ Bradley Tusk closes second fund on $70M

Tusk Venture Partners , the venture capital firm led by Bradley Tusk and managing partner Jordan Nof, has secured $70 million for its second flagship fund, the firm has confirmed to TechCrunch following a report by Fortune this morning. Fundraising for the effort began in January, when the pair filed paperwork with the U.S. Securities Exchange Commission for Tusk Venture Partners II. The firm and affiliated political advisory outfit Tusk Ventures, is behind a number of high-profile startups, including e-scooter ‘unicorn’ Bird, cryptocurrency exchange Coinbase and Ro, a direct-to-consumer healthcare business best known for selling erectile dysfunction medication. The New York-based firm, founded in 2011, previously raised  $36 million for its debut fund — capital it used to back medical marijuana delivery company  Eaze ; the marketplace for household service providers  Handy ; and fintech startup  Grove . Tusk, before launching Tusk Ventures, served as campaign manager for Mike B

New THC and CBD infused beverage company, Cann, joins the race to replace booze

Cann , a Los Angeles-based purveyor of CBD and THC-infused intoxicants, is rolling out its first major distribution through the venture-backed delivery service Eaze as it begins to hit the streets in California. The company founded by two former Bain consultants is the latest to take on the growing market for non-alcoholic intoxicants that use a combination of chemicals traditionally found in the marijuana plant to make their drinks. First dreamed up by Jake Bullock while attending business school at Stanford, Cann launched earlier this month at MedMen and is now selling its $30 multi-flavor six packs both in stores and through Eaze . The beverages come with 2 milligram dose of THC and 5milligrams of CBD per can. Bullock and his partner Luke Anderson met while both men were at Bain Consulting — and both have a background in consumer retail businesses. Bullock initially worked at the investment bank, Allen & Co., before moving over to Bain for consulting and finally settling in